Ceramide nano-liposome as well as preparation method and application thereof

By combining serine, hydrogenated soy lecithin and other components with ceramide, stable ceramide nanoliposomes were prepared, which solved the problem of poor stability and moisturizing effect of existing ceramide liposomes, and achieved low temperatures, Stability and significant moisturizing effect at room temperature and high temperature.

CN119074616APending Publication Date: 2024-12-06济南磐升生物技术有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411259434.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-10
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The existing ceramide liposomes have poor stability and poor moisturizing effects, making it difficult to effectively maintain and repair the skin barrier function.

Method used

Nanoliposomes composed of serine, hydrogenated soy lecithin, tocopherol succinate, cholesterol, vitamin E, HS15, oat oil and Eucalyptus blue leaf extract and ceramide were used to mix and wash and filter through peristaltic pump and hollow fiber column concentration , high-pressure homogenization treatment to form stable ceramide nanoliposomes.

Benefits of technology

It improves the stability of ceramide nanoliposomes at low temperatures, normal temperatures and high temperatures, significantly enhances its moisturizing effect and repair anti-allergic function, and improves the skin barrier function.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
Patent Text Reader

Abstract

The invention provides ceramide nano-liposome as well as a preparation method and application thereof. The ceramide nano-liposome is prepared from the following raw materials: serine, hydrogenated soybean lecithin, tocopherol succinate, cholesterol, VE, HS15, oat oil, a eucalyptus globulus leaf extract and ceramide. Compared with the existing ceramide nano-liposome, the ceramide nano-liposome disclosed by the invention has the advantages that the oat oil, the eucalyptus globulus leaf extract and the serine are added, and the prepared ceramide nano-liposome has relatively good stability at low temperature, normal temperature and relatively high temperature, and is good in water retention effect and relatively good in repairing, anti-allergy and barrier functions.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of liposomes and relates to a ceramide nanoliposome, a preparation method and an application thereof. Background Art

[0002] Ceramide is a type of amide compound formed by dehydration of long-chain fatty acids and sphingosine. It is the main component of intercellular lipids in the stratum corneum of the skin, accounting for 50% of intercellular lipids, and plays an important role in the barrier function. Supplementing ceramide to the skin can maintain and repair the epidermal barrier function, regulate the skin's immune response, reduce water loss, inhibit wrinkles, and achieve moisturizing, whitening, and anti-aging effects.

[0003] Ceramide is insoluble in water and has poor stability, so it is usually encapsulated in liposomes before use. However, existing ceramide liposomes have poor stability and poor moisturizing and repairing effects. Summary of the invention

[0004] The purpose of the present invention is to provide a ceramide nanoliposome, a preparation method and an application thereof, so as to solve the problems of poor stability and poor moisturizing effect of the existing ceramide nanoliposome.

[0005] To achieve the above object, the present invention adopts the following technical solutions: The present application provides a ceramide nanoliposome, wherein the raw materials for preparing the liposome include serine, hydrogenated soybean lecithin, tocopherol succinate, cholesterol, VE, HS15, oat oil, eucalyptus globulus leaf extract and ceramide.

[0006] Serine, also known as β-hydroxyalanine, is a non-essential amino acid. Serine is a small molecule amino acid that is easily absorbed by the skin, preventing dry skin, locking in moisture, and moisturizing. It can also increase skin elasticity. In addition, serine can stimulate the production of collagen and elastic fibers, promote cell division and growth, accelerate nourishment, repair damaged skin, and increase skin firmness.

[0007] Hydrogenated soy lecithin is a type of lecithin that can encapsulate active substances, and also has the functions of repairing the skin, improving absorption rate, and assisting in skin care. In addition, hydrogenated soy lecithin can also penetrate into human skin, replenishing the skin with water, and relieving dry skin to a certain extent.

[0008] Tocopherol succinate is an esterified derivative of tocopherol. It has the anti-aging and antioxidant functions of tocopherol, and also has good light stability and high temperature resistance. Because the phenolic hydroxyl groups in tocopherol succinate are protected, it is not easily oxidized, has good chemical stability, and has better whitening and moisturizing properties.

[0009] Cholesterol is one of the main components of skin cell membranes, helping to build and maintain the integrity of the skin barrier, preventing water loss and the invasion of harmful substances from the outside world. Cholesterol is also involved in the regeneration and repair of skin cells, which helps to accelerate wound healing and repair damaged tissues. In addition, cholesterol can inhibit inflammatory reactions and reduce inflammatory symptoms such as skin redness, swelling, and itching.

[0010] VE is vitamin E, also known as tocopherol. VE can protect the function of skin and mucous membranes, make the skin naturally healthy, and achieve the effect of beauty and skin care.

[0011] HS15 is 15-hydroxystearate polyethylene glycol, which can absorb a large amount of water and retain it inside the skin, thereby providing a long-term hydration and moisturizing effect. HS15 can also promote cell regeneration, accelerate wound healing, and has a good repair effect on skin damage and sunburn. In addition, HS15 can also inhibit the growth of surface bacteria, inhibit the formation of wrinkles, regulate the pH value of the skin, reduce the skin's response to external stimuli, and reduce the risk of skin allergies.

[0012] Oatmeal oil can form an oil film on the skin surface to moisturize and hydrate the skin. It is also rich in linoleic acid Omega-3 and Omega-6, which can stimulate the synthesis of ceramides and effectively repair damaged skin barriers. At the same time, oatmeal oil also has antioxidant effects, which can effectively remove free radicals and reduce wrinkles.

[0013] Eucalyptus globulus leaf extract can accelerate skin repair, lock the moisture in the skin, and achieve the purpose of moisturizing. Eucalyptus globulus leaf extract contains rich antibacterial and antiseptic ingredients, which have an inhibitory effect on histamine, can effectively inhibit the invasion of acne bacteria and other pathogens, reduce the occurrence of skin diseases, and reduce skin allergic reactions. In addition, Eucalyptus globulus leaf extract can also promote keratinocyte proliferation, eliminate free radicals produced in the body, and delay aging. Eucalyptus globulus leaf extract also belongs to natural ingredients, which is very small for skin irritation, and can promote the skin to generate ceramide by itself, which plays a whitening effect. Preferably, the concentration of Eucalyptus globulus leaf extract in this application is 1%, and ceramide is ceramide 3.

[0014] Preferably, the raw materials for preparing the ceramide nanoliposomes provided in the present application include, by mass, 15-30 g of serine, 5-15 g of hydrogenated soy lecithin, 0.01-5 g of tocopherol succinate, 0.01-5 g of cholesterol, 0.01-5 g of VE, 0.01-10 g of HS15, 0.01-5 g of oat oil, 0.01-3 g of eucalyptus globulus leaf extract and 0.01-3 g of ceramide.

[0015] More preferably, the raw materials for preparing the ceramide nanoliposomes provided in the present application include, by mass, 18.75 g of serine, 10.5 g of hydrogenated soy lecithin, 0.2 g of tocopherol succinate, 0.5 g of cholesterol, 1.0 g of VE, 9.0 g of HS15, 0.1 g of oat oil, 0.02 g of eucalyptus globulus leaf extract and 1 g of ceramide.

[0016] The present application provides a method for preparing ceramide nanoliposomes, the method comprising: S01: dissolving serine in water to form an aqueous phase material, wherein the amount of water added is based on the amount of dissolved serine.

[0017] S02: dissolving hydrogenated soybean lecithin, tocopherol succinate, cholesterol, VE, HS15, oat oil, eucalyptus globulus leaf extract and ceramide in anhydrous ethanol to form an oil phase material.

[0018] S03: The water phase material and the oil phase material are mixed after passing through a peristaltic pump respectively, and the obtained mixture is concentrated, filtered and homogenized by a hollow fiber column under high pressure to obtain ceramide nanoliposomes.

[0019] The aqueous phase material is transported by a peristaltic pump with a rotation speed of 100-200rpm, and the oil phase material is transported by a peristaltic pump with a rotation speed of 10-50rpm. The mixing of the aqueous phase material and the oil phase material is achieved through precise material transportation. The mixed material formed after mixing is continuously concentrated and filtered through a hollow fiber column to wash away excess anhydrous ethanol and unencapsulated components. After the concentration and filtration are completed, high-pressure homogenization is performed twice at a pressure of 140MPa by a high-pressure homogenizer to obtain ceramide nanoliposomes.

[0020] The ceramide nanoliposomes in this application are used for skin moisturizing.

[0021] The present invention has the following beneficial effects: Oat oil, eucalyptus globulus leaf extract and serine are added during the preparation of ceramide nanoliposomes. Compared with existing ceramide nanoliposomes, the ceramide nanoliposomes provided in the present application have better stability at low temperature, room temperature and higher temperature, and have good water retention effect, repair and anti-allergy, and better barrier function. DETAILED DESCRIPTION

[0022] The technical solution of the present invention is further explained and illustrated by means of specific embodiments below.

[0023] Example 1 The present application embodiment provides a ceramide nanoliposome, and the raw materials for its preparation include, by mass, 18.75 g of serine, 10.5 g of hydrogenated soy lecithin, 0.2 g of tocopherol succinate, 0.5 g of cholesterol, 1.0 g of VE, 9.0 g of HS15, 0.1 g of oat oil, 0.02 g of 1% eucalyptus globulus leaf extract, and 1 g of ceramide 3.

[0024] The preparation method of ceramide nanoliposomes provided in the present application example includes: S101: Dissolve 18.75 g of serine in 625 mL of water to form an aqueous phase material.

[0025] S102: dissolving hydrogenated soy lecithin, tocopherol succinate, cholesterol, VE, HS15, oat oil, eucalyptus globulus leaf extract and ceramide in 125 mL of anhydrous ethanol according to the above proportions to form an oil phase material.

[0026] S103: The aqueous phase material is transported by a peristaltic pump with a rotation speed of 155 rpm, and the oil phase material is transported by a peristaltic pump with a rotation speed of 30 rpm. The aqueous phase material and the oil phase material are mixed by precise material transportation. The mixed material formed after mixing is continuously concentrated and filtered through a hollow fiber column to wash away excess anhydrous ethanol and unencapsulated components. After the concentration and filtration are completed, high-pressure homogenization is performed twice at a pressure of 140 MPa by a high-pressure homogenizer to obtain ceramide nanoliposomes.

[0027] Example 2 The present application embodiment provides a ceramide nanoliposome, and the raw materials for its preparation include, by mass, 15 g of serine, 5 g of hydrogenated soy lecithin, 1 g of tocopherol succinate, 1 g of cholesterol, 1 g of VE, 5 g of HS15, 2 g of oat oil, 1 g of 1% eucalyptus globulus leaf extract, and 2 g of ceramide 3.

[0028] The preparation method of ceramide nanoliposomes provided in the present application example is: S201: Dissolve 15 g of serine in 600 mL of water to form an aqueous phase material.

[0029] S202: Dissolve hydrogenated soybean lecithin, tocopherol succinate, cholesterol, VE, HS15, oat oil, eucalyptus globulus leaf extract and ceramide in 125 mL of anhydrous ethanol according to the above proportions to form an oil phase material.

[0030] S203: The aqueous phase material is transported by a peristaltic pump with a rotation speed of 100 rpm, and the oil phase material is transported by a peristaltic pump with a rotation speed of 25 rpm. The aqueous phase material and the oil phase material are mixed by precise material transportation. The mixed material formed after mixing is continuously concentrated and filtered through a hollow fiber column to wash away excess anhydrous ethanol and unencapsulated components. After the concentration and filtration are completed, high-pressure homogenization is performed twice at a pressure of 140 MPa by a high-pressure homogenizer to obtain ceramide nanoliposomes.

[0031] Example 3 The present application embodiment provides a ceramide nanoliposome, and the raw materials for its preparation include, by mass, 20 g of serine, 10 g of hydrogenated soy lecithin, 3 g of tocopherol succinate, 3 g of cholesterol, 3 g of VE, 10 g of HS15, 5 g of oat oil, 3 g of 1% eucalyptus globulus leaf extract, and 3 g of ceramide 3.

[0032] The preparation method of ceramide nanoliposomes provided in the present application example includes: S301: Dissolve 20 g of serine in 700 mL of water to form an aqueous phase material.

[0033] S302: Dissolve hydrogenated soybean lecithin, tocopherol succinate, cholesterol, VE, HS15, oat oil, eucalyptus globulus leaf extract and ceramide in 125 mL of anhydrous ethanol according to the above proportions to form an oil phase material.

[0034] S303: The aqueous phase material is transported by a peristaltic pump with a rotation speed of 200 rpm, and the oil phase material is transported by a peristaltic pump with a rotation speed of 35 rpm. The aqueous phase material and the oil phase material are mixed by precise material transportation. The mixed material formed after mixing is continuously concentrated and filtered through a hollow fiber column to wash away excess anhydrous ethanol and unencapsulated components. After the concentration and filtration are completed, high-pressure homogenization is performed twice at a pressure of 140 MPa by a high-pressure homogenizer to obtain ceramide nanoliposomes.

[0035] Example 4 The present application embodiment provides a ceramide nanoliposome, and the raw materials for its preparation include, by mass, 30 g of serine, 15 g of hydrogenated soy lecithin, 5 g of tocopherol succinate, 5 g of cholesterol, 5 g of VE, 10 g of HS15, 5 g of oat oil, 3 g of 1% eucalyptus globulus leaf extract, and 3 3 g of ceramide 3.

[0036] The preparation method of ceramide nanoliposomes provided in the examples of the present application is the same as that in Example 1.

[0037] Example 5 The present application embodiment provides a ceramide nanoliposome, and the raw materials for its preparation include, by mass, 20 g of serine, 8 g of hydrogenated soy lecithin, 0.01 g of tocopherol succinate, 0.01 g of cholesterol, 0.01 g of VE, 1 g of HS15, 0.01 g of oat oil, 0.01 g of 1% eucalyptus globulus leaf extract, and 0.01 g of ceramide 3.

[0038] The preparation method of ceramide nanoliposomes provided in the examples of the present application is the same as that in Example 1.

[0039] Example 6 The present application embodiment provides a ceramide nanoliposome, and the raw materials for its preparation include, by mass, 22g of serine, 12g of hydrogenated soy lecithin, 2.5g of tocopherol succinate, 2.5g of cholesterol, 2.5g of VE, 8g of HS15, 2.5g of oat oil, 1.1g of 1% eucalyptus globulus leaf extract, and 1.5g of ceramide 3.

[0040] The preparation method of ceramide nanoliposomes provided in the examples of the present application is the same as that in Example 1.

[0041] Comparative Example 1 Comparative Example 1 provides a ceramide nanoliposome, and the raw materials for its preparation include, by mass, 18.75 g of serine, 10.5 g of hydrogenated soybean lecithin, 0.2 g of tocopherol succinate, 0.5 g of cholesterol, 1.0 g of VE, 9.0 g of HS15 and 1 g of ceramide 3.

[0042] The preparation method of the ceramide nanoliposomes provided in the comparative example is the same as that in Example 1.

[0043] The present application examples respectively tested the stability and moisture retention of the ceramide nanoliposomes prepared in Example 1 and Comparative Example 1, and the specific tests were as follows: 1. Stability test The ceramide nanoliposomes prepared in Example 1 and Comparative Example 1 were placed at 4° C., 25° C. and 45° C. for 5 weeks, and their stability was observed at the end of each week. The test results are shown in Table 1.

[0044] Table 1: Stability test results As can be seen from Table 1, at a relatively low temperature, such as 4°C, the ceramide nanoliposomes prepared in Example 1 and Comparative Example 1 were all light yellow clear liquids after being placed for 5 weeks, and no stratification occurred. At room temperature, such as 25°C, the ceramide nanoliposomes prepared in Comparative Example 1 were stratified after being placed for 3 weeks, and then flocculated, while the ceramide nanoliposomes prepared in Example 1 of the present application were all light yellow clear liquids after being placed for 5 weeks, and no stratification occurred. At a relatively high temperature, such as 45°C, the ceramide nanoliposomes prepared in Comparative Example 1 were stratified after being placed for 2 weeks, and then flocculated, while the ceramide nanoliposomes prepared in Example 1 of the present application were all light yellow clear liquids after being placed for 5 weeks, and no stratification occurred. This shows that, relative to Comparative Example 1, the ceramide nanoliposomes prepared in Example 1 of the present application have good stability at low temperatures, room temperatures and relatively high temperatures, and no stratification or flocculation occurs.

[0045] 2. Moisture testing 40 women aged 18-40 with sensitive skin, dry, rough skin and easy redness were selected and randomly divided into 2 groups, 20 people in each group. The experimental group applied the ceramide nanoliposomes in Example 1 of the present application, and the control group applied the ceramide nanoliposomes in Comparative Example 1 for 7 consecutive days. The TEWL values ​​of the experimental group and the control group before and after use were measured by a transepidermal water loss tester, and the average value of each group was taken to calculate the rate of change of the TEWL value. The test results are shown in Table 2. Among them, the TEWL value is an important parameter for describing the skin barrier and is closely related to the water content of the stratum corneum of the skin. The higher the TEWL value, the more water is lost through the skin, and the barrier function of the stratum corneum is poor. Change rate = (after use - before use) / before use × 100%, the smaller the change rate, the slower the water loss and the better the barrier function.

[0046] Table 2: Moisture retention test results As can be seen from Table 2, the conversion rate of the ceramide nanoliposomes prepared in Example 1 of the present application before and after use is lower than that of Comparative Example 1, which indicates that the ceramide nanoliposomes provided in the example of the present application have good moisturizing effect, repair and anti-allergic effect, and good barrier function.

[0047] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims

1. A ceramide nanoliposome, characterized in that: The preparation raw materials include: serine, hydrogenated soybean lecithin, tocopherol succinate, cholesterol, VE, HS15, oat oil, eucalyptus globulus leaf extract and ceramide.

2. The ceramide nanoliposome according to claim 1, characterized in that The preparation raw materials include, by mass, 15-30 g of serine, 5-15 g of hydrogenated soybean lecithin, 0.01-5 g of tocopherol succinate, 0.01-5 g of cholesterol, 0.01-5 g of VE, 1-10 g of HS15, 0.01-5 g of oat oil, 0.01-3 g of eucalyptus globulus leaf extract and 0.01-3 g of ceramide.

3. The ceramide nanoliposome according to claim 1, characterized in that The raw materials for preparation include, by mass, 18.75 g of serine, 10.5 g of hydrogenated soy lecithin, 0.2 g of tocopherol succinate, 0.5 g of cholesterol, 1.0 g of VE, 9.0 g of HS15, 0.1 g of oat oil, 0.02 g of eucalyptus globulus leaf extract and 1 g of ceramide.

4. The ceramide nanoliposome according to claim 1, characterized in that The ceramide is ceramide 3.

5. The ceramide nanoliposome according to claim 1, characterized in that The concentration of the eucalyptus globulus leaf extract is 1%.

6. A method for preparing ceramide nanoliposomes, characterized in that: include: Dissolving serine in water to form an aqueous phase material; Dissolving hydrogenated soybean lecithin, tocopherol succinate, cholesterol, VE, HS15, oat oil, eucalyptus globulus leaf extract and ceramide in anhydrous ethanol to form an oil phase material; The aqueous phase material and the oil phase material are mixed after passing through a peristaltic pump respectively, and the obtained mixture is concentrated, filtered and homogenized by a hollow fiber column under high pressure to obtain ceramide nanoliposomes.

7. The method for preparing ceramide nanoliposomes according to claim 6, characterized in that: The rotation speed of the peristaltic pump used for the water phase material is 100-200 rpm, and the rotation speed of the peristaltic pump used for the oil phase material is 10-50 rpm.

8. The method for preparing ceramide nanoliposomes according to claim 6, characterized in that: The pressure of high-pressure homogenization is 140MPa.

9. The ceramide nanoliposomes according to any one of claims 1 to 5 are used for skin moisturizing.